BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3949092)

  • 1. Clinical remission in Crohn's disease--assessment using faecal 111In granulocyte excretion.
    Saverymuttu SH
    Digestion; 1986; 33(2):74-9. PubMed ID: 3949092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease.
    Røseth AG; Schmidt PN; Fagerhol MK
    Scand J Gastroenterol; 1999 Jan; 34(1):50-4. PubMed ID: 10048733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease?
    Crama-Bohbouth G; Pena AS; Biemond I; Verspaget HW; Blok D; Arndt JW; Weterman IT; Pauwels EK; Lamers CB
    Gut; 1989 Sep; 30(9):1236-40. PubMed ID: 2806991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease.
    Saverymuttu SH; Peters AM; Lavender JP; Pepys MB; Hodgson HJ; Chadwick VS
    Gastroenterology; 1983 Dec; 85(6):1333-9. PubMed ID: 6628930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method for assessing intestinal inflammation in Crohn's disease.
    Tibble J; Teahon K; Thjodleifsson B; Roseth A; Sigthorsson G; Bridger S; Foster R; Sherwood R; Fagerhol M; Bjarnason I
    Gut; 2000 Oct; 47(4):506-13. PubMed ID: 10986210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of disease activity in ulcerative colitis using indium-111-labelled leukocyte faecal excretion.
    Saverymuttu SH; Peters AM; Hodgson HJ; Chadwick VS
    Scand J Gastroenterol; 1983 Oct; 18(7):907-12. PubMed ID: 6676924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [111In-oxine marked leukocytes: a method for diagnosing the location and evaluating the activity of Crohn disease and ulcerative colitis].
    Becker W; Fischbach W; Reiners C; Börner W
    Z Gastroenterol; 1985 Oct; 23(10):557-64. PubMed ID: 3936291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of activity parameters in Crohn's disease estimated by the faecal excretion of 111In-labeled granulocytes.
    Fischbach W; Becker W
    Digestion; 1991; 50(3-4):149-52. PubMed ID: 1812041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion.
    Saverymuttu SH; Camilleri M; Rees H; Lavender JP; Hodgson HJ; Chadwick VS
    Gastroenterology; 1986 May; 90(5 Pt 1):1121-8. PubMed ID: 3956932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 111Indium autologous granulocytes in the detection of inflammatory bowel disease.
    Saverymuttu SH; Peters AM; Crofton ME; Rees H; Lavender JP; Hodgson HJ; Chadwick VS
    Gut; 1985 Sep; 26(9):955-60. PubMed ID: 4029721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases.
    Fischbach W; Becker W; Mössner J; Koch W; Reiners C
    Gut; 1987 Apr; 28(4):386-93. PubMed ID: 3495470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome.
    Lahiff C; Safaie P; Awais A; Akbari M; Gashin L; Sheth S; Lembo A; Leffler D; Moss AC; Cheifetz AS
    Aliment Pharmacol Ther; 2013 Apr; 37(8):786-94. PubMed ID: 23432394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing acute phase responses in Crohn's disease and ulcerative colitis.
    Saverymuttu SH; Hodgson HJ; Chadwick VS; Pepys MB
    Gut; 1986 Jul; 27(7):809-13. PubMed ID: 3732890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo assessment of granulocyte migration to diseased bowel in Crohn's disease.
    Saverymuttu SH; Peters AM; Lavender JP; Chadwick VS; Hodgson HJ
    Gut; 1985 Apr; 26(4):378-83. PubMed ID: 3979910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of disease activity in inflammatory bowel disease: a new approach using 111In granulocyte scanning.
    Saverymuttu SH; Lavender JP; Hodgson HJ; Chadwick VS
    Br Med J (Clin Res Ed); 1983 Dec; 287(6407):1751-3. PubMed ID: 6416576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 111In-oxine-labelled white blood cells in the diagnosis and follow-up of Crohn's disease.
    Becker W; Fischbach W; Jenett M; Reiners C; Börner W
    Klin Wochenschr; 1986 Feb; 64(3):141-8. PubMed ID: 3081750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiolabelled granulocytes in inflammatory bowel disease: diagnostic possibilities and clinical indications.
    Becker W; Fischbach W; Weppler M; Mosl B; Jacoby G; Börner W
    Nucl Med Commun; 1988 Oct; 9(10):693-701. PubMed ID: 3062507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 111Indium autologous leucocytes in inflammatory bowel disease.
    Saverymuttu SH; Peters AM; Lavender JP; Hodgson HJ; Chadwick VS
    Gut; 1983 Apr; 24(4):293-9. PubMed ID: 6832626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluticasone propionate in Crohn's disease.
    de Kaski MC; Peters AM; Lavender JP; Hodgson HJ
    Gut; 1991 Jun; 32(6):657-61. PubMed ID: 2060874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [111In-oxine-labeled granulocytes in Crohn disease and ulcerative colitis. Labeling and study technics].
    Becker W; Fischbach W; Reiners C; Börner W
    Rofo; 1985 Mar; 142(3):320-5. PubMed ID: 2984737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.